IDALOPIRDINE, A 5-HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-MODERATE ALZHEIMER’s DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM
Atri A, Frölich L, Ballard C, Tariot P, Molinuevo JL, Boneva N
